Rise of High-Cost Insurance Claims Elevate Need to Mitigate Financial Risks, according to QBE North America's Accident & Health Market Report
"As treatment options grow more advanced and costly, employers are facing rising pressure to control volatility in their self-funded healthcare plans," said
The report shows the frequency of circulatory claims has risen almost 60% post-COVID and neoplasms continue to be the predominant excess loss claim across all deductible levels. Additionally, the severity of preterm birth claims continues to escalate, with some cases reaching close to
Key themes explored in the 2025 report include:
- Increased prevalence of circulatory disease rates post-COVID, particularly among younger patients, is a significant concern
- Emerging high-cost claim trends, including million-dollar claims for cancer, circulatory conditions and pre-term births
- Growing impact of specialty pharmaceuticals and continued strain on patient affordability
- Record-breaking cell and gene therapy approvals, with advanced treatment options for autoimmune diseases and rare genetic conditions
- Societal factors that could be driving the health crisis in America such as antibiotic overuse and processed food consumption
- Legislative challenges to ERISA, as several states introduce bills targeting self-funded health plans
This year's report also highlights
"As the healthcare landscape continues to shift, stop loss insurance remains a critical tool for employers looking to manage risk and protect their plan assets," Krauss added. "Our annual report reinforces
About
View original content to download multimedia:https://www.prnewswire.com/news-releases/rise-of-high-cost-insurance-claims-elevate-need-to-mitigate-financial-risks-according-to-qbe-north-americas-accident--health-market-report-302495749.html
SOURCE